Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Drug Design, Development and Therapy
|
July 26, 2014
New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
Stephanie M Perez, Daniel J Lodge
The International Journal of Neuropsychopharmacology
|
November 4, 2016
Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine
Jennifer J Donegan, Daniel J Lodge
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 15, 2003
The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Regulatory Peptides
|
November 6, 2003
The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Behavioural Brain Research
|
September 1, 2009
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia
Daniel J Lodge, Anthony A Grace
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
August 24, 2010
Developmental pathology, dopamine, stress and schizophrenia
Daniel J Lodge, Anthony A Grace
Trends in Pharmacological Sciences
|
June 25, 2011
Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
Daniel J Lodge, Anthony A Grace
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 18, 2011
Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus
Ornella Valenti, Daniel J Lodge, Anthony A Grace
The International Journal of Neuropsychopharmacology
|
December 25, 2014
Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia
David D Aguilar, Li Chen, Daniel J Lodge
Behavioural Brain Research
|
February 6, 2020
Ketamine: Leading us into the future for development of antidepressants
Flavia R Carreno, Daniel J Lodge, Alan Frazer
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Drug Design, Development and Therapy
|
July 26, 2014
New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
Stephanie M Perez, Daniel J Lodge
The International Journal of Neuropsychopharmacology
|
November 4, 2016
Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine
Jennifer J Donegan, Daniel J Lodge
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 15, 2003
The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Regulatory Peptides
|
November 6, 2003
The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats
Daniel J Lodge, Andrew J Lawrence
Behavioural Brain Research
|
September 1, 2009
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia
Daniel J Lodge, Anthony A Grace
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
August 24, 2010
Developmental pathology, dopamine, stress and schizophrenia
Daniel J Lodge, Anthony A Grace
Trends in Pharmacological Sciences
|
June 25, 2011
Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
Daniel J Lodge, Anthony A Grace
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 18, 2011
Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus
Ornella Valenti, Daniel J Lodge, Anthony A Grace
The International Journal of Neuropsychopharmacology
|
December 25, 2014
Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia
David D Aguilar, Li Chen, Daniel J Lodge
Behavioural Brain Research
|
February 6, 2020
Ketamine: Leading us into the future for development of antidepressants
Flavia R Carreno, Daniel J Lodge, Alan Frazer
Page
of 8